(Q34412632)

2 August 2017

A diagnostic accuracy study of Xpert®MTB/RIF in HIV-positive patients with high clinical suspicion of pulmonary tuberculosis in Lima, Peru (English)

1 reference

2 August 2017

0 references

pulmonary tuberculosis

1 reference

1 reference

Larissa Otero

2

0 references

Carlos Zamudio

object named as

Carlos Zamudio

4

0 references

Carlos Seas

object named as

Carlos Seas

9

0 references

Gabriela Carriquiry

1

object named as

Gabriela Carriquiry

1 reference

2 August 2017

10

Eduardo Gotuzzo

1 reference

2 August 2017

Elsa González-Lagos

3

1 reference

2 August 2017

Eduardo Sánchez

5

1 reference

2 August 2017

Pamela Nabeta

6

1 reference

2 August 2017

Miguel Campos

7

1 reference

2 August 2017

Juan Echevarría

8

1 reference

2 August 2017

language of work or name

English

0 references

publication date

7 September 2012

1 reference

2 August 2017

1 reference

2 August 2017

7

1 reference

2 August 2017

9

1 reference

2 August 2017

e44626

1 reference

Creative Commons Attribution 4.0 International

2 August 2017

start time

7 September 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

False-positive rifampicin resistance on Xpert® MTB/RIF: case report and clinical implications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436871

Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436871

Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436871

Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436871

Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436871

Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436871

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436871

Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436871

Rapid detection of Mycobacterium tuberculosis complex and rifampin resistance in smear-negative clinical samples by use of an integrated real-time PCR method

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436871

Xpert(®) MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436871

Rapid molecular detection of tuberculosis and rifampin resistance

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436871

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436871

HIV infection-related tuberculosis: clinical manifestations and treatment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436871

HIV infection-associated tuberculosis: the epidemiology and the response

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436871

Timing of initiation of antiretroviral drugs during tuberculosis therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436871

Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436871

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436871

The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436871

Are three sputum acid-fast bacillus smears necessary for discontinuing tuberculosis isolation?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436871

Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3436871

Application of the Capilia TB assay for culture confirmation of Mycobacterium tuberculosis complex isolates

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22970271

12 December 2020

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/22970271

12 December 2020

inferred from PubMed ID database lookup

Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22970271

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1371/JOURNAL.PONE.0044626

1 reference

release_nw3ikekco5cirndmv4lyqpzu2y

2 August 2017

0 references

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nw3ikekco5cirndmv4lyqpzu2y

24 November 2022

mapped directly with Wikidata item

PMCID

3436871

1 reference

2 August 2017

1 reference